U.S. flag An official website of the United States government

On Oct. 1, 2024, the FDA began implementing a reorganization impacting many parts of the agency. We are in the process of updating FDA.gov content to reflect these changes.

U.S. Food and Drug Administration
  1. Home
  2. News & Events
  3. FDA Meetings, Conferences and Workshops
  4. Public Calendar - Meetings With FDA Officials
  5. Public Calendar: December 31, 2023-January 6, 2024
  1. Public Calendar - Meetings With FDA Officials

Public Calendar: December 31, 2023-January 6, 2024

This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.

Official Name: Robert M. Califf, M.D., MACC, Commissioner for Food and Drugs

No Significant Event

Official Name: Janet Woodcock, M.D., Principal Deputy Commissioner

No Significant Event

Official Name: Jim Jones, Deputy Commissioner for Human Foods

Event Date: 01/03/2024
Location: College Park, MD
Subject: Introductory Meeting
FDA Participant/Group: MARK MOORMAN; CATHERINE MCDERMOTT; JAMES GORNY; GIRVIN LIGGANS; SAMIR ASSAR;
Non FDA Participant/Group: Connor Kippe, Michael Lavender (National Sustainable Agriculture Coalition);

Event Date: 01/04/2024
Location: Virtual
Subject: Introductory Meeting
FDA Participant/Group: REBECCA BUCKNER; JANESIA ROBBS; PATRICIA HANSEN; DONALD PRATER;
Non FDA Participant/Group: Jason Linde, Robert (Bob) Earl, Sung Poblete (Food Allergy Research and Education);

Official Name: Kimberlee Trzeciak, Deputy Commissioner for Policy, Legislation, and International Affairs

Event Date: 01/05/2024
Location: Virtual
Subject: FDA's Authorization of Florida’s Drug Importation Program
FDA Participant/Group: N/A
Non FDA Participant/Group: Greg Loyst, Kim Godard (Health Canada);

Official Name: Jim Sigg, Deputy Commissioner for Operations

No Significant Event

Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy

No Significant Event

Official Name: Michael Rogers, Associate Commissioner for Regulatory Affairs

No Significant Event

Official Name: Leah Hunter, Associate Commissioner for External Affairs

No Significant Event

Official Name: Namandjé N. Bumpus, Ph.D., Chief Scientist

No Significant Event

Official Name: Patrizia Cavazzoni, M.D., Director, Center for Drug Evaluation and Research

No Significant Event

Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research

Event Date: 01/06/2024
Location: San Francisco, CA
Subject: Longwood Healthcare Leaders: Regulatory and Industry Roundtable
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry, research, and academic stakeholders

Event Date: 01/06/2024
Location: Menlo Park, CA
Subject: International Society for Stem Cell Research Nucleus Forum 2024; Introductory Remarks and Fireside Chat
FDA Participant/Group: N/A
Non FDA Participant/Group: Industry and research stakeholders

Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health

No Significant Event

Official Name: Donald Prater, Acting Director, Center for Food Safety and Applied Nutrition

No Significant Event

Official Name: Brian King, Ph.D., Director, Center for Tobacco Products

No Significant Event

Official Name: Tracey H. Forfa, J.D., Director, Center for Veterinary Medicine

No Significant Event

Official Name: Tucker Patterson, Ph.D., Director, National Center for Toxicological Research

No Significant Event

Official Name: Mark Raza, J.D., Chief Counsel

No Significant Event

 

Back to Top